DOLAN THOMAS CHARLES
Known title: DirectorCIK: 0000933029
DOLAN THOMAS CHARLES's purchase track record
DOLAN THOMAS CHARLES has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 6/27/2023 | MSGE | $10.00M | -0.3% | -3.4% | +9.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
this person other insiders at MSGE
Transaction History
| MSGE | ▲ Buy | Open Market | 322,580 | $10.0M | 6/27/2023 | View on chart |
| MSGE | ▼ Sell | Other | 29,355 | — | 4/20/2023 | View on chart |
| MSGE | ▼ Sell | Other | 1,000 | — | 4/20/2023 | View on chart |
| MSGE | ▼ Sell | Other | 17,773 | — | 4/20/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
MSGE Eyes Strong Q1 Earnings, Potential Re-Rating
Analysts anticipate robust first‑quarter results for Madison Square Garden Entertainment, which could prompt a re‑rating of the stock. The company sits near a neutral RSI and a key support level around $75.96, within its 52‑week range. A positive earnings surprise may lift the share toward its analyst target of $91.62.
MSGE Eyes Strong Q1 Earnings, Potential Re-Rating. Analysts anticipate robust first‑quarter results for Madison Square Garden Entertainment, which could prompt a re‑rating of the stock. The company sits near a neutral RSI and a key support level around $75.96, within its 52‑week range. A positive earnings surprise may lift the share toward its analyst target of $91.62.